Eyewire News: The Podcast

Eyewire News: The Podcast

Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.

Episodes

Visionary Breakthroughs: A Spotlight on Innovations in Eye Care (Part 1 of 2)

September 24, 2025 • 18 mins
Industry executives discuss future innovations and breakthroughs that are poised to reshape the future of ophthalmic care.  Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Breaking News From the ESCRS Congress in Copenhagen

September 17, 2025 • 16 mins
EyewireTV reports on new products and breaking news live from the ESCRS Congress in Copenhagen.  Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Vision Advocacy Leaders Speak Out Against Proposed NEI Cuts

September 10, 2025 • 15 mins
A proposal by the Trump Administration calls for cuts to the National Institutes of Health and consolidation of the federal government’s 27 institutes into just eight. This includes folding the National Eye Institute into a new broader institute on neuroscience and brain research. Ophthalmic leaders discuss what the vision care advocacy community is doing to combat proposed cuts to the National Eye Institute.  Learn more about your...
Mark as Played

Update on Investigational Treatments for Retinal Diseases

September 3, 2025 • 7 mins
Several companies with treatment candidates for retinal diseases provide clinical updates; Nicox releases new phase 3 data for its investigational glaucoma eye drop; the first patient is implanted with Ocumetics’ novel accommodating lens; and ASCRS provides details for its second annual Business of Refractive Cataract Surgery Summit. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

CE Certification for New Glaucoma Surgical Implant

August 27, 2025 • 4 mins
Ciliatech obtains CE certification for the Intercil Uveal Spacer surgical implant; Zeiss receives CE mark for a new device that uses AI to automate OCT assessment; and the FDA extends the target action dates for two Eylea HD submissions. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Special Report: TFOS DEWS III Leaders Discuss New DED Guidance

August 20, 2025 • 10 mins
Leaders from the Tear Film and Ocular Surface Society discuss the biggest takeaways from the recently released TFOS DEWS III report. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

First Commerical Surgeries Performed with MacTel Therapy

August 13, 2025 • 8 mins
Charles Wykoff, MD, PhD, shares his experience performing the first commercial case for a patient with MacTel; VSY Biotechnology launches its Enova Hydrophobic IOLs with a new preloaded delivery system; and an app is launched that syncs AI directly to leading OCT devices. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Alcon Acquires Staar for $1.5 Billion

August 6, 2025 • 13 mins
Alcon makes a major acquisition to expand its refractive portfolio; the CEO of Lenz Therapeutics joins us to discuss the FDA approval of a new presbyopia drop; and the optical industry braces for major changes as new reciprocal tariffs are set to begin this week.   Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Tryptyr Now Available in US

July 30, 2025 • 4 mins
Alcon launches its recently approved dry eye drug Tryptyr; a potential $1 billion deal is made to advance extended-release therapies for eye diseases; and two companies with late-stage AMD drug candidates complete phase 3 enrollment. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Harrow Adds Biosimilars to US Portfolio

July 23, 2025 • 4 mins
Harrow enters a deal to expand it biosimilar pharma portfolio; the first gene-agnostic therapy to restore vision in RP patients advances; and Aldeyra provides an update on its dry eye drug candidate reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

AECOS Presentation Summaries

July 16, 2025 • 10 mins
Leading ophthalmologists share summaries of their presentations live from thee AECOS Summer Symposium.     Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Alcon Acquires LumiThera

July 9, 2025 • 6 mins
Alcon makes a major acquisition to bolster is vitreoretinal surgery portfolio; the European Commission (EC) approves Eylea 8 mg for extended treatment intervals; and Eric Donnenfeld, MD, discusses the business of myopia management. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Glaukos' MIGS Technology Certified in Europe; New Phase 3 Data for Presbyopia Drop

July 2, 2025 • 5 mins
Glaukos receives European Union certification for several of its MIGS technologies; Opus Genetics and Viatris present phase 3 results for their investigational presbyopia eye drop; and J&J launches the first and only daily disposable contact lens for people with both astigmatism and presbyopia.  Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Special Report: Update on Holland Foundation

June 25, 2025 • 8 mins
The leaders of the Holland Foundation provide an update on the progress of the foundation and its mission to restore sight for patients with Severe Ocular Surface Disease. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

TFOS DEWS III Published

June 18, 2025 • 5 mins
The Tear Film and Ocular Surface Society publishes the third installment of the TFOS DEWS report; J&J launches the Tecnis Odyssey presbyopia-correcting IOL in Europe, the Middle East, and Canada; and Harrow acquires the exclusive US commercial rights to postoperative inflammation and pain drug Byqlovi. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

First Myopia Drug Approved in Europe

June 11, 2025 • 4 mins
The first pharmaceutical treatment for myopia is approved in Europe; the FDA sets a target action date for a first-of-its-kind presbyopia drop; and John Berdahl, MD, discusses the reimbursement landscape in ophthalmology.  Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Alcon Gains FDA Approval for Novel DED Drug

June 4, 2025 • 8 mins
Alcon receives FDA approval for a novel pharmaceutical treatment for dry eye disease; Genentech’s Susvimo ocular implant is approval for a third indication in the US; and the makers of two investigational treatments for wet AMD complete enrollment in their respective phase 3 trials.  Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Special Report: Executives Discuss Overcoming Challenges

May 28, 2025 • 21 mins
Ophthalmology executives share challenging situations they encountered, as well as the steps needed to overcome the challenge. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

B+L Launches New Scleral Lenses Technology

May 21, 2025 • 3 mins
B+L launches a new scleral lenses technology in the US; New World Medical introduces a transparent tip on its Streamline Surgical System, and an OCT platform is cleared in Europe.   Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

B+L Receives Approval in Europe for LuxLife IOL

May 14, 2025 • 5 mins
Bausch + Lomb receives CE Mark for a new full range of vision IOL; Aldeyra plans to once again resubmit a new drug application to the FDA for dry eye drug candidate reproxalap; and Topcon makes several deals to advance its AI and digital health solutions Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Popular Podcasts

    On Purpose with Jay Shetty

    On Purpose with Jay Shetty

    I’m Jay Shetty host of On Purpose the worlds #1 Mental Health podcast and I’m so grateful you found us. I started this podcast 5 years ago to invite you into conversations and workshops that are designed to help make you happier, healthier and more healed. I believe that when you (yes you) feel seen, heard and understood you’re able to deal with relationship struggles, work challenges and life’s ups and downs with more ease and grace. I interview experts, celebrities, thought leaders and athletes so that we can grow our mindset, build better habits and uncover a side of them we’ve never seen before. New episodes every Monday and Friday. Your support means the world to me and I don’t take it for granted — click the follow button and leave a review to help us spread the love with On Purpose. I can’t wait for you to listen to your first or 500th episode!

    Stuff You Should Know

    Stuff You Should Know

    If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

    The Joe Rogan Experience

    The Joe Rogan Experience

    The official podcast of comedian Joe Rogan.

    True Crime Tonight

    True Crime Tonight

    If you eat, sleep, and breathe true crime, TRUE CRIME TONIGHT is serving up your nightly fix. Five nights a week, KT STUDIOS & iHEART RADIO invite listeners to pull up a seat for an unfiltered look at the biggest cases making headlines, celebrity scandals, and the trials everyone is watching. With a mix of expert analysis, hot takes, and listener call-ins, TRUE CRIME TONIGHT goes beyond the headlines to uncover the twists, turns, and unanswered questions that keep us all obsessed—because, at TRUE CRIME TONIGHT, there’s a seat for everyone. Whether breaking down crime scene forensics, scrutinizing serial killers, or debating the most binge-worthy true crime docs, True Crime Tonight is the fresh, fast-paced, and slightly addictive home for true crime lovers.

    The Clay Travis and Buck Sexton Show

    The Clay Travis and Buck Sexton Show

    The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.

Advertise With Us
Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

Explore

iHeart

Live Radio

Podcasts

Artist Radio

Exclusives

News

Features

Events

Contests

Photos

Information

About

Advertise

Blog

Brand Guidelines

Contest Guidelines

Subscription Offers

Jobs

Get the App

Automotive

Home

Mobile

Wearables

© 2025 iHeartMedia, Inc.